Dopamine deficiency in the basal ganglia (a set of subcortical structures) causes severe motor dysfunctions, such as slowness of movements (bradykinesia), as observed in Parkinson's disease. Dopamine binds D1 and D2 receptors that are expressed in the nerve cells of the striatum (a structure of the basal ganglia), and exerts different effects on the nerve cells. However, how dopamine controls through these receptors the information flow in the basal ganglia and voluntary movements is still not clear.

A new study finds that rising placebo responses may play a part in the increasingly high failure rate for clinical trials of drugs designed to control chronic pain caused by nerve damage. Surprisingly, however, the analysis of clinical trials conducted since 1990 found that the increase in placebo responses occurred only in trials conducted wholly in the U.S.; trials conducted in Europe or Asia showed no changes in placebo responses over that period.

Calcium is a crucial element in the body that controls thought, movement and other bodily functions. These events are directed by specialized proteins called ion channels that allow the flow of calcium ions in and out of cells and among cell compartments. For years, scientists have been unsure how calcium ion channels function.

New atomic scale images of the structure of calcium's gatekeeper, IP3R, could go a long way toward solving this mystery and lead to treatments for the many diseases tied to channel malfunctions.

The IP3R channel was imaged by scientists in the Department of Biochemisty and Molecular Biology at The University of Texas Health Science Center at Houston (UTHealth). Their findings appear in the journal Nature.

Primary care providers are put in a difficult position when screening their male patients for prostate cancer--some guidelines suggest that testing the general population lacks evidence whereas others state that it is appropriate in certain patients. Now a new perspective piece offers some guidance on when to screen patients and how to involve them in decisions about screening and treatment.

Scientists have calculated more precise measurements of heritability--the influence of underlying genes--in nine autoimmune diseases that begin in childhood. The research may strengthen researchers' abilities to better predict a child's risk for associated autoimmune diseases.

Autoimmune diseases, such as type 1 diabetes, Crohn's disease and juvenile idiopathic arthritis, collectively affect one in 12 persons in the Western Hemisphere. They represent a significant cause of chronic disability.

Biologists have developed a nonsurgical method to deliver long-term contraception to both male and female animals with a single shot - but only in mice.-

The road map is to as an alternative to spaying and neutering feral animals.

The approach was developed in the lab of Bruce Hay, professor of biology and biological engineering at Caltech, who leveraged work conducted in recent years by David Baltimore and others showing that an adeno-associated virus (AAV)--a small, harmless virus that is unable to replicate on its own, that has been useful in gene-therapy trials--can be used to deliver sequences of DNA to muscle cells, causing them to produce specific antibodies that are known to fight infectious diseases, such as HIV, malaria, and hepatitis C.